Abstract
Tumor necrosis factor-alpha (TNF-alpha)-inhibiting agents are a standard therapy for moderate-to-severe inflammatory bowel disease (IBD). IgA nephropa......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
